Anthony Bet, MBA

Clinical Manager
Stanford University, United States

Disclosure information not submitted.

Presentation(s):

• First-in-human Phase 1/2a Study of Intracerebral Transplantation using Embryonic-derived Neural Stem Cells (NR1) for Chronic Ischemic Stroke

  Saturday, May 4, 2024
  2:37 PM – 2:43 PM CT